selegos 5 mg - תוצאות חיפוש

neopharm ltd - desvenlafaxine as succinate 50 mg - tablets extended release - desvenlafaxin - pristiq , a selective serotonin and norepinephrine reuptake inhibitor (snri) , is indicated for the treatment of major depressive disorder (mdd).

ישראל - עברית - Ministry of Health

פריסטיק 100 מ"ג

neopharm ltd - desvenlafaxine as succinate 100 mg - tablets extended release - desvenlafaxin - pristiq , a selective serotonin and norepinephrine reuptake inhibitor (snri) , is indicated for the treatment of major depressive disorder (mdd).

ישראל - עברית - Ministry of Health

מדיקינט mr כמוסות בשחרור מושהה 20 מ"ג

mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

ישראל - עברית - Ministry of Health

מודיקיט mr כמוסות בשחרור מושהה 30 מ"ג

mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.